Ivbar receives SEK 50M from Summa Equity.


Ivbar, a Stockholm, Sweden-based company providing competitive intelligence for the health industry, announced raising SEK 50M ($5.8M) in an equity investment round. The money comes from Summa Equity and will be used for supoport in Ivbar's next phase of development, with funding and support to scale up the businesses for broader roll-out and growth acceleration.

Ivbar, founded in 2011 and led by CEO Jonas Wohlin, has developed a big data analytics platform, ERA Vision, that enables improved management of healthcare through a focus on patient value.

The platform improves transparency and provides unique levels of insight into both health outcomes and resource allocation, and is useful for both payors and providers of healthcare. ERA Vision is used for advanced benchmarking, performance monitoring and calculation of reimbursement.

Total investments received (USD): 6.14M